Elevated site urgencyFDA Class II

Paroxetine Extended-Release Tablets, 37

Failed dissolution specifications.

Agency
FDA Drug
Recall date
Sep 23, 2026
Status
Ongoing
Company
Apotex Corp.

1. What product was recalled?

Paroxetine Extended-Release Tablets, 37

Paroxetine Extended-Release Tablets, 37.5mg, 30-count bottle, Rx only, Manufactured by: Apotex Inc., Toronto, Ontario, Canada M9L 1T9, Manufactured for: Apotex Corp., Weston, Florida 33326, NDC 60505-1318-3

Code or lot text: Lot# TY9495, Exp Date: 05/2027.

LOT
Exp Date: 05/2027.
LOT
Lot# TY9495
NDC
60505-1316
NDC
60505-1316-3
NDC
60505-1317
NDC
60505-1317-3
NDC
60505-1318
NDC
60505-1318-3
NDC
60505-3673
NDC
60505-3673-3
NDC
60505-3674
NDC
60505-3674-3
NDC
60505-3675
NDC
60505-3675-3
RECALL-NUMBER
D-0877-2026
UPC
0360505367337
UPC
0360505367436
UPC
0360505367535

2. Is my exact product affected?

Compare every printed identifier. A matching value can indicate that your product is included.

3. What is the hazard?

Failed dissolution specifications.

4. What should I do now?

Follow the FDA recall notice and contact the recalling company for current instructions.

5. Where was it sold or distributed?

Nationwide

6. Were injuries or illnesses reported?

No separate injury or illness statement was present in the normalized record. Check the official source for the latest report.

7. What remedy is available?

Follow the FDA recall notice and contact the recalling company for current instructions.

8. Is the recall active or closed?

The source status is Ongoing. The Recall Guy's urgency label is elevated, which is a separate deterministic site label.

9. When was the information checked?

Last checked .

  1. created

10. Where is the official source?

Open the official FDA Drug source

The Recall Guy normalizes public source data for easier checking. Source agencies remain authoritative. Confirm identifiers and instructions at the official source.